Related Experiment Video
Updated: Jul 19, 2026
06:56
Generating a Fractal Microstructure of Laminin-111 to Signal to Cells
Published on: September 28, 2020
Expression profiling characterization of laminin alpha-2 positive MDC.
Caterina Millino1, Milena Bellin, Marina Fanin
1CRIBI Biotechnology Center and Dipartimento di Biologia, Università degli Studi di Padova, Padova, Italy.
Biochemical and Biophysical Research Communications
|October 3, 2006
Summary
Congenital muscular dystrophies (MDC) transcriptomes reveal distinct molecular profiles. Expression profiling identified mild and severe phenotypes in laminin alpha-2 (LAMA2) positive MDC, aiding understanding of this heterogeneous condition.
Area of Science:
- Molecular Biology
- Genetics
- Neuromuscular Disorders
Background:
- Congenital muscular dystrophies (MDC) are a group of inherited muscle diseases.
- Patients are often classified based on laminin alpha-2 (LAMA2) deficiency or positivity.
- LAMA2-positive MDC is genetically heterogeneous with unknown specific defects.
Purpose of the Study:
- To investigate the skeletal muscle transcriptome in LAMA2-deficient and LAMA2-positive MDC patients.
- To identify molecular differences associated with disease severity and phenotype.
- To enhance understanding of the molecular basis of LAMA2-positive MDC.
Main Methods:
- Studied skeletal muscle transcriptome using cDNA microarrays.
- Analyzed gene expression profiles from four LAMA2-deficient and six LAMA2-positive MDC patients.
- Correlated expression profiling with histopathological and clinical classifications.
Main Results:
- Expression profiling delineated two patient groups: mild and severe phenotypes.
- The mild phenotype showed delayed slow-to-fast muscle fiber maturation.
- Underexpression of telethonin and myosin light-chains 3 and 1V was noted in the mild group.
Conclusions:
- Skeletal muscle transcriptome analysis can define distinct MDC phenotypes.
- Expression profiling aligns with histopathology and partially with clinical data.
- This approach offers insights into the molecular underpinnings of LAMA2-positive MDC.
